Showing 1 - 10 of 342
Persistent link: https://www.econbiz.de/10001702597
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without compensation to the patent holders. The question of whether this...
Persistent link: https://www.econbiz.de/10013212342
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without compensation to the patent holders. The question of whether this...
Persistent link: https://www.econbiz.de/10012469480
Persistent link: https://www.econbiz.de/10006972441
Persistent link: https://www.econbiz.de/10013342357
Persistent link: https://www.econbiz.de/10001075364
Persistent link: https://www.econbiz.de/10001181905
Persistent link: https://www.econbiz.de/10001136313
Persistent link: https://www.econbiz.de/10006534159
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without compensation to the patent holders. The question of whether this...
Persistent link: https://www.econbiz.de/10005012915